Quick Answer
UNITED THERAPEUTICS Corp reported Operating Income of $1.49 billion for fiscal year 2025.
UNITED THERAPEUTICS Corp Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $1.49B | +8.4% |
| 2024 | $1.38B | +16.2% |
| 2023 | $1.18B | +20.9% |
| 2022 | $979.70M | +76.2% |
| 2021 | $555.90M | -6.4% |
| 2020 | $593.60M | +416.4% |
| 2019 | -$187.60M | -123.3% |
| 2018 | $805.40M | -1.2% |
| 2017 | $814.90M | -23.2% |
| 2016 | $1.06B | +51.9% |
| 2015 | $699.00M | +29.7% |
| 2014 | $538.80M | +84.2% |
| 2013 | $292.50M | -30.6% |
| 2012 | $421.65M | +32.7% |
| 2011 | $317.78M | +85.5% |
| 2010 | $171.31M | +565.1% |
| 2009 | $25.76M | +131.4% |
| 2008 | -$82.06M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $388.50M | +13.2% | +6.6% |
| June 30, 2025 | $364.50M | +13.9% | -4.8% |
| March 31, 2025 | $382.80M | +7.4% | +11.6% |
| September 30, 2024 | $343.10M | +4.9% | +7.3% |
| June 30, 2024 | $319.90M | +2.1% | -10.2% |
| March 31, 2024 | $356.30M | +25.3% | +9.0% |
| September 30, 2023 | $327.00M | +4.0% | +4.3% |
| June 30, 2023 | $313.40M | +55.3% | +10.2% |
- UNITED THERAPEUTICS Corp showed an increase of +8.4% in Operating Income compared to the prior fiscal year.
- Over the 2008–2025 period, UNITED THERAPEUTICS Corp’s operating income has grown by 1918.9% (from -$82.06 million to $1.49 billion).
- The most recent figure is from UNITED THERAPEUTICS Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: